Scott Plevy, M.D.

Portrait
Scott Plevy, M.D., Executive Vice President and Therapeutic Head, Gastroenterology

Dr. Plevy is a gastroenterologist and molecular immunologist who most recently served as Chief Scientific Officer at Senda Biosciences. He previously held the role of Chief Scientific Officer at Synlogic Therapeutics, and also served as Vice President, Immunology Research and Development at Janssen Pharmaceuticals, where he contributed to the discovery, development, launch and label expansion of several important drugs, including Stelara®. Since the start of his career, Dr. Plevy has published over 110 peer-reviewed scientific papers in areas including novel immunologic interventions in inflammatory bowel disease and other immunologic disorders. He has completed multiple early-phase clinical trials where he served as the lead investigator. Dr. Plevy earned B.A. and M.D. degrees from Columbia University. He completed his residency in internal medicine at Brigham and Women's Hospital.